-
Aug 9, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Carenostics is a healthcare AI startup founded with the mission of addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML on existing healthcare data.
Full story
-
Aug 8, 2023, 01:00 AM
by
User Not Found
Bio-IT World | “Generate Biomedicines’ goal of leveraging machine-learning powered generative biology to discover and develop new drugs faster and cheaper is supported by an integrated and cohesive R&D data platform… FAIR to its core, this integrated data platform leverages industry best practices and lessons-learned from a talented team of informatics engineers to form the critical foundation of a unique company with equal parts ‘bio’ and ‘tech’.”
Full story
-
Aug 3, 2023, 10:02 AM
by
Full story
-
Aug 3, 2023, 09:29 AM
by
The Lactocore Group has joined BioLabs Heidelberg, marking a significant expansion in the European Union of innovative research and development in the field of peptide therapy for the treatment of depression, anxiety and metabolic disorders.
Full story
-
Aug 3, 2023, 09:29 AM
by
Full story
-
Aug 3, 2023, 01:00 AM
by
User Not Found
Bio-IT World | The prognosis of lung carcinoma has changed since the discovery of molecular targets and their specific drugs. Somatic EGFR mutations have been reported in lung carcinoma, and these mutant proteins act as substrates for targeted therapies.
Full story
-
Aug 2, 2023, 09:05 AM
by
Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader.
Full story
-
Aug 2, 2023, 09:05 AM
by
Titian Software LTD and Evotec have signed a 3-year agreement to expand their collaboration around Titian Software’s Mosaic Sample Management Platform.
Full story
-
Aug 2, 2023, 09:05 AM
by
Expert Speaker Lineup Revealed for Award Winning RBQM Event
Full agenda and keynote speakers announced for industry-leading risk-based quality management event focusing on the global transformation and evolution of RBQM, sponsored by CluePoints.
Full story
-
Aug 2, 2023, 09:05 AM
by
Scientists attend national patient retreat and share scientific updates on investigational EMD-101 for severe congenital neutropenia treatment
Full story
-
Aug 2, 2023, 09:05 AM
by
DNAnexus announced a collaboration with BigOmics Analytics to provide customers with a fully integrated solution to better understand large-scale proteomics and transcriptomics data.
Full story
-
Aug 2, 2023, 09:05 AM
by
The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change
Clinical trial participants, caregivers and health professionals share unfiltered accounts of their personal health journeys and provide insights into their experience in clinical trials.
Full story
-
Aug 2, 2023, 01:00 AM
by
User Not Found
Bio-IT World | The field of drug discovery is shifting its approach from viewing complex biology as something to be overcome using reductionist principles to something to embrace in a more holistic approach to cell biology.
Full story
-
Aug 1, 2023, 09:12 AM
by
Researchers uncover a detailed action mechanism for protein MRG15, an important consideration for drugs targeting ASH1L which is overexpressed in many cancers. The findings from King Abdullah University of Science and Technology (KAUST), Saudi Arabia and the University of Michigan, U.S, could implicate the design of future cancer treatments.
Full story
-
Aug 1, 2023, 01:00 AM
by
User Not Found
Bio-IT World | A group of scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University and MIT are convinced that automated machine learning (autoML) is going to revolutionize biology by removing many of the technical barriers to using computational models to answer fundamental questions about sequences of nucleic acids, peptides, and glycans.
Full story
-
Jul 28, 2023, 08:17 AM
by
Rapidly growing African population and urbanization, an increasing number of chronic diseases, and growing healthcare spending's are some of the primary factors driving the growth of the African pharmaceutical market.
Full story
-
Jul 28, 2023, 08:16 AM
by
Full story
-
Jul 28, 2023, 08:16 AM
by
Full story
-
Jul 27, 2023, 08:47 AM
by
Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.
Hunan Huateng Pharmaceutical Co. Ltd.
Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China
Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China
Email: sales@huatengusa.com
Website: https://us.huatengsci.com
Zip code: 410205
Telephone: +86 731 89916275
Fax: +86 0731-82251112-818
Full story
-
Jul 27, 2023, 08:45 AM
by
Full story